Artificial Intelligence continues to pave new paths in oncology!

During the 125th Congresso Nazionale di Oncologia, held from October 11th to 13th, Francesco Trovò, from our partner Politecnico di Milano, presented advancements in his talk titled “L’Intelligenza Artificiale in Oncologia” that are making a real difference in cancer treatment.

Trovò explained how AI techniques are helping predict the effectiveness of immunotherapy treatments in patients with non-small cell lung cancer. This technology is not only allowing treatments to be tailored to each patient’s specific needs, but also improving the precision of clinical trials and enhancing predictive capabilities.

Thank you, Francesco, and the POLIMI team for your participation in the congress!

Stay tuned for more information and don’t forget to follow us on our social networks:

LinkedIn | Twitter | Instagram | Facebook

Share on: